Show simple item record

dc.contributor.advisorPeter Hutten_US
dc.contributor.authorSun, Xiaopu
dc.date.accessioned2012-04-18T14:04:31Z
dc.date.issued2008
dc.identifier.citationXiaopu Sun, An Analysis of New Drug Examination and Approval System of PRC (April 2008).en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8592050
dc.description.abstractThis paper analyzes the new drug examination and approval systems before and after the Measures was amended in 2007 and evaluates the effectiveness of the 2007 Amendment. In Part One, this paper introduces the new drug examination and approval system before the Measures were amended in 2007 and analyzes its disadvantages. Part Two of the paper describes the changes brought by the 2007 Amendment to the Measures and evaluates their effectiveness with regard to drug safety. Part Three discusses the impacts of the Agreement between the Department of Health and Human Services of the United States of America and the SFDA of the People’s Republic of China on the Safety of Drugs and Medical Devices on Chinese new drug regulation system. In the end, the author concludes that although the tendency of stricter supervision of government authority is obviously beneficial for the guarantee of drug safety, the effective implementation of the legal schemes is still a big issue in China.en_US
dash.licenseLAA
dc.subjectFood and Drug Lawen_US
dc.subjectFDA Enforcement-Regulation of Foreign Commerce-Foreign Lawen_US
dc.subject.otherFood and Drug Lawen_US
dc.titleAn Analysis of New Drug Examination and Approval System of PRCen_US
dc.typePaper (for course/seminar/workshop)en_US
dc.relation.journalFood and Drug Law: An Electronic Book of Student Papersen_US
dc.date.available2012-04-18T14:04:31Z


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record